Navigation Links
Specialized MRI scans assess value of anti-cancer chemotherapy long before tumors shown to shrink
Date:6/28/2012

high-precision, 3-D images, taken shortly before and one month after a form of chemotherapy called transcatheter arterial chemoembolization, could assess the treatment's impact against a rare and advanced form of liver bile duct cancer, known as cholangiocarcinoma. The study involved 29 men and women aged 29 to 82, all undergoing treatment at The Johns Hopkins Hospital.

Among the key findings in the first study was that 22 people, whose functional MRI scans showed increases in apparent diffusion coefficient scores of over 45 percent, lived at least 10 months longer, while some 17 with coefficient score increases over 60 percent, lived at least 17 months longer.

Kamel, an associate professor at the Johns Hopkins University School of Medicine and its Russell H. Morgan Department of Radiology, says that cholangiocarcinoma is often diagnosed at such an advanced stage that patients only have on average six months to live. "By the time our patients become jaundiced, start turning yellow from bile buildup and seek medical help, it's almost too late," he says. "They have no time to waste on failed treatments."

The second study, also at Johns Hopkins, tested the scans on 26 men and women, ages 37 to 79, with islet cell carcinoma, a well-known pancreatic cancer. Researchers analyzed some 215 tumorous lesions in these people, scanning shortly before and one month after the same initial treatment for their cancer.

Kamel says physicians have more treatment options with islet cell carcinoma and can switch people from chemoembolization to chemotherapy with either drug Sunitinib or Everolimus.

Results in the second study showed that for 78 tumors, which responded well to chemotherapy, functional MRI scans produced apparent diffusion coefficient score increases averaging at least 70 percent, while in the 137 tumors for which treatment was not a success, increases in coefficient measures averaged less than 40 percent. Treatment was
'/>"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Specialized care by experienced teams cuts death and disability from bleeding brain aneurysms
2. High-contrast, high-resolution CT scans now possible at reduced dose
3. Child CT Scans Might Up Risk of Brain Cancer, Leukemia
4. People Love Talking About Themselves, Brain Scans Show
5. Study Downplays Risk of CT Scans
6. CT Scans Deliver More Radiation to Obese People: Study
7. Diagnostic Scans Tied to Radiation Risk for Gastro Patients
8. Study examines use of a natural language processing tool for electronic health records in assessing colonoscopy quality
9. Global Energy Assessment identifies pathways to a sustainable energy future
10. Assessing Olympic terrorism threats
11. SYNERGY HomeCare Offers Free Home Safety Assessments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... 2015 , ... For over twenty years, Doctors on Liens has ... the company’s history the goal has been to be a comprehensive network of doctors ... And while Doctors on Liens has certainly achieved that goal, the addition of ...
(Date:7/6/2015)... ... ... “ TapGlance ” was featured on NewsWatch as part of its monthly AppWatch, which ... Android, and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the ... what rooms will look like before they even start renovating.. , Whether a person ...
(Date:7/6/2015)... ... July 06, 2015 , ... Acara Partners, ... announces the return of its complimentary educational webinar series for the ... leaders creates success for their clients through targeted marketing, sales, digital communications, branding ...
(Date:7/6/2015)... ... 06, 2015 , ... Understanding the new ICD-10 requirements is ... the transition. ADVOCATE, the only 100% radiology, revenue cycle management company in the ... The ten tips are timely and relevant guidelines to help radiology practices avoid ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... Health care ... the ability of the medical field to access and use this “Big Data” to ... MD, President and Chief Executive Officer of the Mount Sinai Health System in New ...
Breaking Medicine News(10 mins):Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5
... 26 Anesiva, Inc. (Nasdaq: ANSV ), ... today that it is planning to commence a rights ... fully subscribed, produce gross proceeds to Anesiva of an ... non-transferable rights to subscribe for and purchase notes to ...
... Stem Cell Therapy Association (ASCTA) is formed in response to the ... cells found in everyone,s body are drugs, a position the ASCTA ... allow doctors to bring adult stem cell therapy to their patients ... ...
... AMERIGROUP Corporation (NYSE: AGP ) today announced ... Healthcare Conference on April 8 in New York City.A live ... at 11:00am Eastern Time, can be accessed on AMERIGROUP,s Web ... will be available for 30 days, and can be accessed ...
... CLARITA, Calif., March 26 The Association of Professional ... by a group of pooper scoopers who believe every ... growing problem in our communities, environment and water tables, ... owners on the importance of cleaning up after their ...
... Accessible and Cost-Effective OptionFORT COLLINS, Colo., March 26 ... option that builds immunity to food allergens from ... treatment that gently builds tolerance to targeted foods. ... allergy shots. It quickly builds immunity to allergens ...
... The Finnish Health,Care System: A Value-Based Perspective highlights new ... Finland. The report utilizes,Michael E. Porter,s model on value-based ... Over the last few years, the world-famous ... Porter has been analysing the,effectiveness of health care. One ...
Cached Medicine News:Health News:Anesiva Announces Planned Rights Offering 2Health News:Anesiva Announces Planned Rights Offering 3Health News:Physician Group Opposes FDA's Position on Adult Stem Cells 2Health News:Physician Group Opposes FDA's Position on Adult Stem Cells 3Health News:International Pooper Scooper Week - April 1-7 2Health News:New OTC Allergy Treatment Available to Food Allergy Sufferers 2Health News:Finland Seeks Systemic Changes in Health Care 2
(Date:7/6/2015)... , July 6, 2015 Hologic, Inc. ... plans to release its financial results for the third ... after the market closes.  In conjunction with the release, ... 4:30 p.m. Eastern Time. Interested participants may ... the United States ) or 719-325-4804 (for ...
(Date:7/6/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/58tdl6/pharmaceutical ) ... Sodium Chloride Market by Applications, by Region - Industry ... offering. The pharmaceutical grade sodium chloride market ... 2014 and 2019 in terms of volume, and the ... The report on Pharmaceutical grade sodium chloride ...
(Date:7/6/2015)... July 6, 2015 Array BioPharma,s (NASDAQ: ... this past weekend at the 2015 ESMO World ... At the meeting, data were shared from a ... 100-patient randomized Phase 2 expansion of that trial ... EGFR inhibitor, with or without the addition of ...
Breaking Medicine Technology:Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4
... , ORLANDO, Fla. , May 19 ... of medicine to their daily routine.  In 2009, drug trend ... increased 10.8 percent, driven by a 5 percent increase in ... 2010 Drug Trend Report.  The growth in prescription drug use ...
... May 19 Five presentations reporting the ... LYSTEDA™ (tranexamic acid) tablets, a novel, first-in-class, non-hormonal therapy ... bleeding (HMB), were presented at The American College of ... San Francisco , May 15-19, 2010 .  It ...
Cached Medicine Technology:New Research: Kids' Consumption of Chronic Medications on the Rise 2New Research: Kids' Consumption of Chronic Medications on the Rise 3New Research: Kids' Consumption of Chronic Medications on the Rise 4New Research: Kids' Consumption of Chronic Medications on the Rise 5Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 2Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 3Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 4Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 5Clinical Data Demonstrates That LYSTEDA™ Significantly Reduced Menstrual Blood Loss and Limitations on Social, Leisure and Physical Activities in Women With Cyclic HMB 6
... A necessary addition to ... the Reichert Trial Frame ... and smooth controls for ... robust design, high-quality materials, ...
... The Ultramatic Rx Master is ... years of reliable service and ... that measurably improve procedures. It ... need and want most, including ...
The Maverick Over-The-Wire balloon catheter delivers a new level of performance to meet the changing demands of interventional cardiology....
... Illumination is provided by a cool-running, energy ... only what you need to see without ... of all they are maintenance free so ... bulb. Every Phoroptor comes with a limited ...
Medicine Products: